Birmingham-based Rampart IC, a medical device company specializing in radiation shielding, has signed agreements that expand its distribution to Israel, Hong Kong, United Arab Emirates, Qatar, Kuwait, Oman, Egypt, and Canada. The company has existing agreements with distributors throughout Europe, Australia, New Zealand, and Japan. Rampart manages direct sales in the United States.

The Rampart M1128 is a radiation shielding device for interventionalists. It is an adjustable, mobile structure that supports transparent lead acrylic panels to create a protective wall between the medical team and the radiation source, which allows interventionalists to work without the heavy lead aprons that can cause orthopedic injuries.

Although the Rampart M1128 device was originally developed for interventional cardiologists because of the extended time they spend in catheterization labs, resulting in one of the highest levels of radiation exposure in the world, the device is beginning to be used by several interventional specialties.